MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
1.090
0.000
0.00%
After Hours: 1.080 -0.01 -0.92% 19:14 04/30 EDT
OPEN
1.090
PREV CLOSE
1.090
HIGH
1.090
LOW
1.025
VOLUME
221.30K
TURNOVER
--
52 WEEK HIGH
4.690
52 WEEK LOW
1.025
MARKET CAP
14.01M
P/E (TTM)
-1.0034
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CANF last week (0421-0425)?
Weekly Report · 2d ago
Weekly Report: what happened at CANF last week (0414-0418)?
Weekly Report · 04/21 09:35
Can-Fite BioPharma Gains FDA Compassionate Use Approval for Namodenoson
TipRanks · 04/17 13:47
Can-Fite BioPharma says medical centers seek authorization for namodenoson
TipRanks · 04/17 13:03
Can-Fite BioPharma: US Medical Centers Approach FDA For Compassionate Use Approval To Treat Patients With Pancreatic Carcinoma With Oncological Drug Namodenoson
Benzinga · 04/17 12:57
FOLLOWING FDA COMPASSIONATE USE APPROVAL FOR PANCREATIC CARCINOMA WITH CAN-FITE’S NAMODENOSON, LEADING U.S. MEDICAL CENTERS SEEK AUTHORIZATION FOR THEIR PATIENTS
Reuters · 04/17 12:55
Biotech Alert: Searches spiking for these stocks today
TipRanks · 04/16 15:55
Can-Fite BioPharma Announces $3 Million Direct Offering
TipRanks · 04/15 16:58
More
About CANF
More
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Recently
Symbol
Price
%Change

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.